SC 13G/A: Amneal Pharmaceuticals, Inc.

Ticker: AMRX · Form: SC 13G/A · Filed: Apr 24, 2024 · CIK: 1723128

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Amneal Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

Filing Stats: 1,413 words · 6 min read · ~5 pages · Grade level 9.2 · Accepted 2024-04-24 06:03:48

Key Financial Figures

Filing Documents

Ownership

Item 4. Ownership. (a) See Item 9 of the cover pages to this Schedule 13G for the aggregate number of Class A Common Stock that are beneficially owned by each Reporting Person as of March 31, 2024. (b) See Item 11 of the cover pages to this Schedule 13G for the percentage of Class A Common Stock that are beneficially owned by each Reporting Person as of March 31, 2024. (c) See Items 5 through 8 of the cover pages to this Schedule 13G for the number of Class A Common Stock that are beneficially owned by each Reporting Person as of March 31, 2024 as to which there is sole or shared power to vote or direct the vote, and sole or shared power to dispose or direct the disposition.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Ownership of More than Five Percent on Behalf of Another

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. See Item 2.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 5 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 24, 2024 AMBIENT IMPACT (HK) LIMITED By: /s/ Ma King Yin Ma King Yin Director FOSUN INTERNATIONAL LIMITED By: /s/ SZE Mei Ming SZE Mei Ming Company Secretary Page 6 of 7 EXHIBIT INDEX Exhibit No. Description 99.1 Joint Filing Agreement dated September 28, 2018 by and between Ambient Impact (HK) Limited and Fosun International Limited (incorporated by reference to Exhibit 99.1 to that certain Schedule 13G filed on September 28, 2018 by the Reporting Persons with the Securities and Exchange Commission). Page 7 of 7

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing